BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  FORMA Therapeutics and the University of Oxford Announce Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors for the Treatment of Neurodegenerative Diseases

  FORMA expands translational footprint in Neurodegeneration with ARUK Oxford Drug Discovery Institute

  May 9, 2018

   · 

  4 min read
• Business

  Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders

  Provention acquires PRV-031 and plans to initiate pivotal Phase 3 clinical trial to intercept early-onset type 1 diabetes, a pediatric orphan indication

  May 9, 2018

   · 

  7 min read
• Business

  Cardax Reports Q1 2018 Results

  - ZanthoSyn® Sales Nearly 3-Fold Higher Than Q1 2017 - ZanthoSyn® #1 In Hawaii GNC Stores For Two Quarters In A Row - Accelerating Sales Trend In California And Nevada

  May 9, 2018

   · 

  3 min read
• Business

  Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

  Collaboration provides Genentech with access to Lodo Therapeutics’ proprietary metagenomics-based natural products drug discovery platform Lodo to receive up to $969 million in upfront fees and milestone payments

  May 9, 2018

   · 

  3 min read
• Pharm Country

  Spheryx Publishes Results on Advantages of Multi-Color Sources for Holographic Characterization of Particles in Optics Express

  A paper demonstrating the advantages of using multiple lasers of different colors to enhance the capabilities of their proprietary technology, Total Holographic Characterization®, for the detection and monitoring of particles in suspensions, has been published in the peer-reviewed journal Optics Express.

  May 9, 2018

   · 

  2 min read
• Business

  Amarillo Announces $69M Investment in Veterinary School to Meet Regional and Global Demand

  Agreement ensures construction of Texas Tech University School of Veterinary Medicine in the heart of Texas’ livestock industry

  May 9, 2018

   · 

  3 min read
• Drug Development

  Bonti Announces Start of LANTERN-2 Phase 2 Clinical Trial Evaluating EB-001T in Treating Focal Muscle Pain

  Program aimed at treating focal muscle pain and reducing use of rescue medications, including opioids.

  May 9, 2018

   · 

  5 min read
• Genetown

  Axial Biotherapeutics Reports Findings of Elevated 4-Ethylphenylsulfate (4-EPS) in Replicate Analyses of Serum Samples from Children with Autism Spectrum Disorder (ASD)

  First Results from Axial’s ASD Program Presented at the International Society for Autism Research (INSAR) Conference

  May 9, 2018

   · 

  3 min read
• FDA

  AcelRx resubmits New Drug Application for DSUVIA™

  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use in medically supervised settings, today announced the resubmission of the New Drug Application (NDA) for DSUVIA with the U.S. Food and Drug Administration (FDA)

  May 9, 2018

   · 

  5 min read
• Genetown

  LogicBio Therapeutics Launches Development Program in Methylmalonic Acidemia (MMA)

  Preclinical data demonstrate potential for LB-001 to address the underlying cause of MMA

  May 9, 2018

   · 

  4 min read